Evidence map›Paper›PMID 35619220›Full record

ArticleAging2022

Aryl hydrocarbon receptor blocks aging-induced senescence in the liver and fibroblast cells.

Ana Nacarino-Palma, Eva M Rico-Leo, Judith Campisi, Arvind Ramanathan, Francisco J González-Rico, Claudia M Rejano-Gordillo, Ana Ordiales-Talavero, Jaime M Merino, Pedro M Fernández-Salguero

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ana Nacarino-PalmaDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Extremadura, Badajoz 06071, Spain.
Eva M Rico-LeoDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Extremadura, Badajoz 06071, Spain.
Judith CampisiBuck Institute for Research on Aging, Novato, CA 94945, USA.
Arvind RamanathanBuck Institute for Research on Aging, Novato, CA 94945, USA.
Francisco J González-RicoDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Extremadura, Badajoz 06071, Spain.
Claudia M Rejano-GordilloDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Extremadura, Badajoz 06071, Spain.
Ana Ordiales-TalaveroDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Extremadura, Badajoz 06071, Spain.
Jaime M MerinoDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Extremadura, Badajoz 06071, Spain.
Pedro M Fernández-SalgueroDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Extremadura, Badajoz 06071, Spain.
Universidad de Extremadura · ESBuck Institute for Research on Aging · USLawrence Berkeley National Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging impairs organismal homeostasis leading to multiple pathologies. Yet, the mechanisms and molecular intermediates involved are largely unknown. Here, we report that aged aryl hydrocarbon receptor-null mice (

Indexed as

Cyclin-Dependent Kinase Inhibitor p16Receptors, Aryl HydrocarbonAgingAnimalsCellular SenescenceFibroblastsLiverMiceCyclin-Dependent Kinase Inhibitor p16Receptors, Aryl Hydrocarbonaryl hydrocarbon receptorhepatocarcinogenesismetabolismsenescence

Identifiers

PMID35619220
PMCPMC9186759
OpenAlexW4281682461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.